Skip to content

Comparaison of ESP Block and TAP Block

ESP Versus TAP for Analgesia After Laparoscopic Cholecystectomy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04176770
Enrollment
80
Registered
2019-11-25
Start date
2019-12-01
Completion date
2020-06-30
Last updated
2019-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Operative Pain

Keywords

Laparoscopic cholecystectomy, Post Operative, Analgesia

Brief summary

This study aim to compare the efficiency and the analgesic effect of Erector Spinal Plane Block versus TAP Block after laparoscopic cholecystectomy.

Detailed description

This study will include patients scheduled for laparoscopic cholecystectomy, ASA status 1 or 2. patients will be randomized in 2 groups to recieve post operative analgesia with -ESP block: bilateral injection of 20 ml of isobaric Bupivacain 0,375% in the paraverebral space T5. or -TAP block: bilateral injection of 15 ml of Isobaric Bupivacain 0,5%

Interventions

PROCEDUREESP Block

ESP block: bilateral injection of 20 ml of isobaric Bupivacain 0,375% in the paraverebral space T5.

PROCEDURETAP Block

TAP block: bilateral injection of 15 ml of Isobaric Bupivacain 0,5%

Sponsors

Mongi Slim Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Adult patients * ASA status I or II * scheduled for laparoscopic cholecystectomy

Exclusion criteria

* laparotomy * unplanned ICU admission

Design outcomes

Primary

MeasureTime frameDescription
Post Operative analgesia24 hours after interventionPost operative analgesia assessed with Numerical rating scale (0=minimum, 10= Maximum)

Secondary

MeasureTime frameDescription
post operative analgesic consumption24 hours after interventionAmount of Morphin needed for analgesia

Countries

Tunisia

Contacts

Primary ContactMhamed Sami Mebazaa, professor
msmebazaa@gmail.com0021622252589
Backup ContactAsma Ben Souissi, Ass Prof
bsouissiasma@gmail.com0021698336883

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026